Search results for "Nitrofuran"

showing 10 items of 20 documents

CCDC 2122176: Experimental Crystal Structure Determination

2022

Related Article: Liāna Orola, Anatoly Mishnev, Dmitrijs Stepanovs, Agris Bērziņš|2022|ChemRxiv|||doi:10.26434/chemrxiv-2022-rb0xk

Space GroupCrystallographyCrystal SystemCrystal StructureCell Parameters1-{[3-(5-nitrofuran-2-yl)prop-2-en-1-ylidene]amino}imidazolidine-24-dione 14-dioxane solvateExperimental 3D Coordinates
researchProduct

CCDC 2122147: Experimental Crystal Structure Determination

2022

Related Article: Liāna Orola, Anatoly Mishnev, Dmitrijs Stepanovs, Agris Bērziņš|2022|ChemRxiv|||doi:10.26434/chemrxiv-2022-rb0xk

Space GroupCrystallographyCrystal SystemCrystal StructureCell Parameters1-{[3-(5-nitrofuran-2-yl)prop-2-en-1-ylidene]amino}imidazolidine-24-dione NN-dimethylacetamide solvateExperimental 3D Coordinates
researchProduct

CCDC 2121392: Experimental Crystal Structure Determination

2022

Related Article: Liāna Orola, Anatoly Mishnev, Dmitrijs Stepanovs, Agris Bērziņš|2022|ChemRxiv|||doi:10.26434/chemrxiv-2022-rb0xk

Space GroupCrystallographyCrystal SystemCrystal StructureCell Parameters1-{[3-(5-nitrofuran-2-yl)prop-2-en-1-ylidene]amino}imidazolidine-24-dione NN-dimethylformamide solvateExperimental 3D Coordinates
researchProduct

CCDC 2222725: Experimental Crystal Structure Determination

2022

Related Article: Lia̅na Orola, Anatoly Mishnev, Dmitrijs Stepanovs, Agris Be̅rziņš|2022|Cryst.Growth Des.|23|873|doi:10.1021/acs.cgd.2c01114

Space GroupCrystallographyCrystal SystemCrystal StructureCell Parameters1-{[3-(5-nitrofuran-2-yl)prop-2-en-1-ylidene]amino}imidazolidine-24-dione dimethyl sulfoxideExperimental 3D Coordinates
researchProduct

CCDC 2122135: Experimental Crystal Structure Determination

2022

Related Article: Liāna Orola, Anatoly Mishnev, Dmitrijs Stepanovs, Agris Bērziņš|2022|ChemRxiv|||doi:10.26434/chemrxiv-2022-rb0xk

Space GroupCrystallographyCrystal SystemCrystal StructureCell Parameters1-{[3-(5-nitrofuran-2-yl)prop-2-en-1-ylidene]amino}imidazolidine-24-dione formic acid solvate monohydrateExperimental 3D Coordinates
researchProduct

CCDC 928882: Experimental Crystal Structure Determination

2022

Related Article: Liāna Orola, Anatoly Mishnev, Dmitrijs Stepanovs, Agris Bērziņš|2022|ChemRxiv|||doi:10.26434/chemrxiv-2022-rb0xk

Space GroupCrystallographyCrystal SystemCrystal StructureCell Parameters1-{[3-(5-nitrofuran-2-yl)prop-2-en-1-ylidene]amino}imidazolidine-24-dione formic acid solvateExperimental 3D Coordinates
researchProduct

CCDC 2222740: Experimental Crystal Structure Determination

2022

Related Article: Lia̅na Orola, Anatoly Mishnev, Dmitrijs Stepanovs, Agris Be̅rziņš|2022|Cryst.Growth Des.|23|873|doi:10.1021/acs.cgd.2c01114

Space GroupCrystallographyCrystal SystemCrystal StructureCell Parameters1-{[3-(5-nitrofuran-2-yl)prop-2-en-1-ylidene]amino}imidazolidine-24-dione formic acid solvateExperimental 3D Coordinates
researchProduct

Determination of 5-nitrofurylacrylic acid in wines by high-performance liquid chromatography

1988

WineChromatographyAqueous normal-phase chromatographyNitrofuransmedicine.drug_classChemistryOrganic ChemistryWineGeneral MedicineBiochemistryHigh-performance liquid chromatographyAnalytical ChemistryNitrofurylacrylic acidColumn chromatographyAcrylatesmedicineSupercritical fluid chromatographyIndicators and ReagentsChromatography columnNitrofuranChromatography High Pressure LiquidMutagensJournal of Chromatography A
researchProduct

Iatrogenic pulmonary lesions.

2018

Treatment of patients often includes the administration of medications and sometimes radiation. While the intent is to treat an underlying condition, in some cases, adverse effects occur due to these agents. Most of these adverse effects are mild, however, some can be severe and life-threatening. Furthermore, while these effects are often reversible upon cessation of exposure, especially if the inciting agent is recognized and withdrawn early, others might be permanent or even progressing. Most common histopathologic findings in drug-induced interstitial lung disease include nonspecific interstitial pneumonia (cellular and/or fibrotic), organizing pneumonia with or without bronchiolitis, eo…

medicine.medical_specialtyPathologyDrug-Related Side Effects and Adverse ReactionsPolymersIatrogenic DiseaseAmiodaroneAntineoplastic Agents030204 cardiovascular system & hematologyPathology and Forensic Medicine03 medical and health sciences0302 clinical medicineEarly Medical InterventionmedicineEosinophilic pneumoniaHumansImmunologic FactorsIntensive care medicineDiffuse alveolar damageAdverse effectLungLungRadiotherapybusiness.industryInterstitial lung diseasePulmonary edemamedicine.diseasemedicine.anatomical_structureEquipment and SuppliesNitrofurantoin030220 oncology & carcinogenesisPulmonary hemorrhagebusinessLung Diseases InterstitialAnti-Arrhythmia AgentsHydrophobic and Hydrophilic InteractionsHypersensitivity pneumonitisSeminars in diagnostic pathology
researchProduct

Racionāla antibakteriālo līdzekļu lietošana akūta nekomplicēta cistīta gadījumā

2015

Akūts nekomplicēts cistīts ir bieži sastopama infekcija, kuras ārstēšanai ir piemērotas dažādu grupu antibiotikas. Darba mērķis ir noskaidrot, vai Latvijā pacienti racionāli lieto antibiotikas urīnceļu infekciju ārstēšanai. Mērķa sasniegšanai tika veikta aptauja. Iegūtie dati liecina, ka visbiežāk urīnceļu infekcijas gadījumā pacienti lieto nitrofurantoīnu (47%), tad β-laktāma grupas antibiotikas(32%),fluorkvinolonu grupas antibiotikas (13%) un TMP/SMX kombināciju(8%). Cefalosporīnu grupas antibiotikas netika lietotas nevienā gadījumā. Pētījuma respondenti uzskata, ka racionāli lieto antibiotikas urīnceļu infekcijas ārstēšanai, tomēr rezultāti parādīja, ka ne visi ir pietiekami informēti pa…

racionāla lietošanaurīnceļu infekcijaFarmācijaaptaujanitrofurantoīnscistīts
researchProduct